Oncology Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer
Conferences New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting. Among clinical topics, new data in early settings and continued development of immunotherapies stood out to oncologists as areas that can change their practice in the immediate future.
Covid-19 Q3 Earnings Calls Presented a Case for Cautious Optimism Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing
Conferences ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital. While the virtual format has undoubtedly impacted attendees’ experiences and
Customer Engagement The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions During the COVID-19 pandemic, video conferences have proven to drive much better results compared to phone calls for oncology sales interactions.
Oncology Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers. Oncologist-patient relationships are based
Customer Engagement Exploring Factors Influencing Individualized Treatment: Breast Cancer Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.
Conferences ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at
Conferences ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and
Covid-19 Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of
Conferences ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to
Conferences Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting. In
Conferences Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,
Promotional Tracking Evaluating Print vs. Digital Aids in Oncology Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions: The conventional logic is that digital aids enable sales reps to
Promotional Tracking We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years. This post was updated with refreshed data as of 1/30. The high-level findings as reported by Fierce Pharma are available here. Below are 4 keys to driving high-impact details... Oncology sales strategies
Conferences Oncologists reflect on ASCO 2019 The data shared at this year's ASCO Annual Meeting moved the field of clinical oncology forward. Our survey with over 60 oncologists who attended the conference shows that ASCO 2019 did not disappoint.
Conferences Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting With ASCO just days away, oncologists are divided in their outlook for this year's meeting. In our survey of 54 practicing oncologists who plan on attending the conference, half (52%) reported they expect
